×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Clinical: NTRX-07 Phase 2 (NCT07058688) - NeuroTherapia cholinergic an
clinical
789 words
KG: NTRX-07 Phase 2 (NCT07058688) - NeuroTherapia cholinergic anti-inflammatory
2026-03-28
kind:clinical-trial
section:clinical-trials
topic:alzheimers
state:published
Contents
NTRX-07 Phase 2 (NCT07058688) - NeuroTherapia cholinergic anti-inflammatory
Knowledge Graph
Related Hypotheses (10)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.51
TREM2-mediated microglial tau clearance enhancement
Score: 0.78
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.65
TREM2-Dependent Microglial Senescence Transition
Score: 1.00
SASP-Mediated Cholinergic Synapse Disruption
Score: 0.84
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.81
Phase-Separated Organelle Targeting
Score: 0.77
APOE-TREM2 Interaction Modulation
Score: 0.76
Stress Granule Phase Separation Modulators
Score: 0.73
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.69
Show 5 more
Related Analyses (10)
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Microglial subtypes in neurodegeneration — friend vs foe
neuroscience · failed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Show 5 more
Related Experiments (6)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Show 1 more
Knowledge Graph (1 edges)
NTRX-07 Phase 2 (NCT07058688) - NeuroTherapia cholinergic anti-inflammatory
references
TREM2